![Kevin Koch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Koch
Chief Executive Officer at
EDGEWISE THERAPEUTICS, INC.
Net worth: 13 M $ as of 31/05/2026
Profile
Kevin Koch was the founder of Array BioPharma, Inc., founded in 1998, where the title held was President & Chief Scientific Officer from 2012 to 2013.
Current jobs include President, Chief Executive Officer & Director at Edgewise Therapeutics, Inc. since 2020; Director at Encycle Therapeutics, Inc.; Director at Neurogastrx, Inc. since 2018; Director at Skyhawk Therapeutics, Inc.; and Venture Partner at OrbiMed Advisors Private Equity since 2016.
Former jobs include Associate Director-Medicinal Chemistry at Amgen, Inc. from 1995 to 1998; Director at Inflammation Research Association, Inc. from 1998 to 2003; Director at Ataxion, Inc.; Independent Director at Viridian Therapeutics, Inc. from 2017 to 2020; Director at Terremoto Biosciences, Inc. from 2021 to 2023; Senior Vice President-Drug Discovery at Biogen, Inc. from 2013 to 2015; and Senior Research Investigator at Pfizer Inc. from 1988 to 1995.
Education includes a doctorate from Rochester Christian University and an undergraduate degree from Stony Brook University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 369,399 ( 0.34% ) | 13 M $ | 31/05/2026 |
Kevin Koch active positions
| Companies | Position | Start |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Chief Executive Officer | 01/08/2017 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01/05/2016 |
Encycle Therapeutics, Inc.
 Encycle Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Director/Board Member | - |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Director/Board Member | 04/01/2018 |
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Director/Board Member | - |
Former positions of Kevin Koch
| Companies | Position | End |
|---|---|---|
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Director/Board Member | 01/12/2023 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 28/10/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2015 |
| ARRAY TECHNOLOGIES, INC. | Founder | 29/11/2013 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Kevin Koch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Inflammation Research Association, Inc.
 Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology | Commercial Services |
Ataxion, Inc.
 Ataxion, Inc. BiotechnologyHealth Technology Develops novel therapies for rare, debilitating, and underserved neurologic diseases | Health Technology |
Encycle Therapeutics, Inc.
Encycle Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Health Technology |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
- Stock Market
- Insiders
- Kevin Koch
Choose MarketScreener 
